Reliability of IUS in Crohn's Disease

Recruiting now · Not applicable

Conditions studied: Crohn Disease (CD)

In brief

Transabdominal intestinal ultrasound (IUS) is gaining acceptance as a point-of-care test to objectively assess disease activity in Crohn's disease (CD). In order to incorporate individual parameters in a future definition of transmural healing, and for the consistent application of IUS as a modality to assess treatment outcomes and establish therapeutic targets to ensure comparability between future studies, the inter-observer agreement should be determined for all relevant parameters.

Key facts

Study ID

NCT06833450

Run by

Centre Hospitalier Universitaire, Amiens

People needed

30

Starts

2022-01-19

Expected to finish

2026-02-01

Last updated by the study team

2025-02-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Crohn's disease evolving for at least 1 months
• Patient older than 18 years
• Patient covered by French national health insurance
• Written informed consent

You may not qualify if…

• Pregnant women or breastfeeding
• Minor
• Patient deprived of liberty by administrative or judicial decision or placed under judicial protection (guardianship or supervision)

Where it is running

• CHU d'Amiens — Amiens, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.